| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/17/2001 | CA2386878A1 Lipoxin a4 and its analogs for the treatment of dry eye |
| 05/17/2001 | CA2386636A1 15-hydroxyeicosatetraenoic acid-related compounds and methods of use |
| 05/17/2001 | CA2386632A1 Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye |
| 05/17/2001 | CA2386623A1 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use |
| 05/17/2001 | CA2386619A1 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 05/17/2001 | CA2386333A1 3-heteroatom substituted and two carbon homologs 15-hete and methods of use |
| 05/17/2001 | CA2359955A1 Human vanilloid receptor gene |
| 05/16/2001 | EP1098906A1 Peptide analogues of pacap |
| 05/16/2001 | EP1098870A2 Nitric esters and nitrate salts of specific drugs |
| 05/16/2001 | EP1098649A1 Method for stabilizing pharmaceutical compositions by special use of an antioxidant |
| 05/16/2001 | EP1098642A1 Methods for treating conditions modulated by lactosylceramide |
| 05/16/2001 | EP0842165B1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
| 05/16/2001 | EP0695300B1 Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
| 05/16/2001 | CN1295677A Methods and apparatus for accelerated orthokeratology |
| 05/16/2001 | CN1295579A Therapeutic uses of keratinocyte growth factor-2 |
| 05/16/2001 | CN1295563A 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists |
| 05/16/2001 | CN1295560A C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
| 05/16/2001 | CN1295483A Gelling ophthalmic composition containing xanthan gum |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295476A 眼用组合物 Ophthalmic compositions |
| 05/16/2001 | CN1295474A Method for stabilizing pharmaceutical composition by special use of antioxidant |
| 05/15/2001 | USRE37180 Photochemotherapeutical obstruction of newly-formed blood vessels |
| 05/15/2001 | US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/15/2001 | US6232308 Useful for inhibiting bone resorption, treating and preventing osteoporosis, inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, and angiogenesis |
| 05/15/2001 | US6232305 Substituted amino bicyclic-β-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 05/15/2001 | US6232097 Nucleotide sequences coding enzymatic polypeptide; prevent bacterial infection; wound healing agents; for vaccine development |
| 05/15/2001 | US6232064 Fibrosis and atherosclerosis determination |
| 05/15/2001 | CA2180011C Botulinum toxins for treating sweating |
| 05/10/2001 | WO2001032926A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | WO2001032910A2 27 human secreted proteins |
| 05/10/2001 | WO2001032837A1 19 human secreted proteins |
| 05/10/2001 | WO2001032690A1 Substituted dipeptides having nos inhibiting activity |
| 05/10/2001 | WO2001032675A1 32 human secreted proteins |
| 05/10/2001 | WO2001032657A1 Antibiotic sultam and sultone derived oxazolidinones |
| 05/10/2001 | WO2001032654A2 Novel heterocyclic compounds and their use as medicines |
| 05/10/2001 | WO2001032653A1 Heterocyclic substituted pyrazolones |
| 05/10/2001 | WO2001032651A1 Quinazoline derivatives as vegf inhibitors |
| 05/10/2001 | WO2001032649A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 05/10/2001 | WO2001032639A1 Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 05/10/2001 | WO2001032629A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 05/10/2001 | WO2001032621A1 Novel indole derivatives and drugs containing the same as the active ingredient |
| 05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | WO2001032222A1 Selective toxin expression in angiogenic endothelial cells |
| 05/10/2001 | WO2001032216A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 05/10/2001 | WO2001032156A2 Methods for treating fibroproliferative diseases |
| 05/10/2001 | WO2001015719A3 Treatment of conjunctivitis |
| 05/10/2001 | WO2000063241A3 Methods and compositions for modulating an immune response |
| 05/10/2001 | US20010001100 For treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence |
| 05/10/2001 | CA2389807A1 Heterocyclic substituted pyrazolones |
| 05/10/2001 | CA2389773A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | CA2389751A1 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | CA2389690A1 Selective toxin expression in angiogenic endothelial cells |
| 05/10/2001 | CA2389661A1 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 05/10/2001 | CA2389439A1 Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 05/10/2001 | CA2388822A1 27 human secreted proteins |
| 05/10/2001 | CA2387799A1 19 human secreted proteins |
| 05/10/2001 | CA2387613A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 05/10/2001 | CA2386641A1 32 human secreted proteins |
| 05/10/2001 | CA2383992A1 Antibiotic sultam and sultone derived oxazolidinones |
| 05/09/2001 | EP1097926A1 Thiobenzimidazole derivatives |
| 05/09/2001 | EP1097150A1 Imidazolyl derivatives |
| 05/09/2001 | EP1097149A1 Bicyclohexane derivatives |
| 05/09/2001 | EP1097147A1 Novel angiogenesis inhibitors |
| 05/09/2001 | EP1096975A2 Methods for reducing intraocular pressure using a3-adenosine antagonists |
| 05/09/2001 | EP1096945A1 Lysine binding fragments of angiostatin |
| 05/09/2001 | EP1096943A1 Method of preparation and pharmaceutical composition of an uncaria water soluble extract |
| 05/09/2001 | EP1096934A1 Oxazolidinones to treat eye infections |
| 05/09/2001 | EP1096932A2 Antihypertensive combination of valsartan and calcium channel blocker |
| 05/09/2001 | CN1294590A Method of 3-substituted adenines via 2-thioxanthines |
| 05/09/2001 | CN1294579A Sulfonamide-contg. indole compounds |
| 05/09/2001 | CN1294511A Medicinal compsns. |
| 05/09/2001 | CN1294017A Ceramide lipsome emulsion containing VA and its preparing process and usage |
| 05/09/2001 | CN1293955A Anti-infective, antipyretic and antalgic medicine able to treat ophthalmopathy |
| 05/09/2001 | CN1065428C Matrix type patch preparations |
| 05/08/2001 | US6229025 Process for alkylating hindered sulfonamides |
| 05/08/2001 | US6229013 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 05/08/2001 | US6228861 Benign prostatic hyperplasia; anticholesterol agents; impotency; intraocular pressure; antiarrhythmia agents |
| 05/08/2001 | US6228859 Antiasthmatic, antiinflammatory, antiallergen and antidepressant agents |
| 05/08/2001 | US6228834 Treating gramnegative bacterial infections; neutralizing lipopolysaccharides |
| 05/08/2001 | US6228619 Glucosaminidase |
| 05/08/2001 | US6228584 Nucleotide sequences for use in the detection of streptococcus |
| 05/08/2001 | US6227304 Upper hitch link |
| 05/08/2001 | CA2029694C Heteroatoms-containing tricyclic compounds |
| 05/03/2001 | WO2001031008A2 Human and rat fgf-20 genes and gene expression products |
| 05/03/2001 | WO2001030781A2 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION |
| 05/03/2001 | WO2001030766A1 Phthalazinone derivatives as pde 4 inhibitors |
| 05/03/2001 | WO2001030388A1 Tension-relieving agents for ciliary muscle |
| 05/03/2001 | WO2001030386A1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 05/03/2001 | WO2001030383A2 Medicament in order to induce tolerance |
| 05/03/2001 | WO2001030380A2 Methods and compositions for treatment of keratoconus using protease inhibitors |
| 05/03/2001 | WO2001030375A2 Use of gdnf for treating corneal defects |
| 05/03/2001 | WO2001030362A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 05/03/2001 | WO2001030353A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 05/03/2001 | WO2001030323A2 Controlled-release biocompatible ocular drug delivery implant devices and methods |
| 05/03/2001 | WO2001016164A3 Treatment of allergic rhinitis |
| 05/03/2001 | WO2000077168A3 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS |
| 05/03/2001 | WO2000066107A3 Antimalarian agents for the treatment of asthma |
| 05/03/2001 | WO2000065028A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 05/03/2001 | WO2000054813A3 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| 05/03/2001 | DE19951970A1 Arzneimittel für die Toleranzinduktion Medicines for tolerance induction |